Cleared Abbreviated

K991225 - MTI 1 ML SYRINGE

K991225 is the FDA 510(k) clearance for MTI 1 ML SYRINGE by Micro Therapeutics, Inc.. It is a Class 2 General Hospital device (product code FMF) cleared through the Abbreviated 510(k) pathway after a 87-day FDA review.

K991225 · Micro Therapeutics, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1999
Decision
87d
Days
Class 2
Risk

K991225 is an FDA 510(k) clearance for the MTI 1 ML SYRINGE. Classified as Syringe, Piston (product code FMF), Class II - Special Controls.

Submitted by Micro Therapeutics, Inc. (San Clemente, US). The FDA issued a Cleared decision on July 8, 1999 after a review of 87 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5860 - the FDA general hospital device framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Micro Therapeutics, Inc. devices

Submission Details

510(k) Number K991225 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 12, 1999
Decision Date July 08, 1999
Days to Decision 87 days
Submission Type Abbreviated
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
42d faster than avg
Panel avg: 129d · This submission: 87d
Pathway characteristics
Standards-based clearance path.

Device Classification

Product Code FMF Syringe, Piston
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5860
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FMF Syringe, Piston

All 258
Devices cleared under the same product code (FMF) and FDA review panel - the closest regulatory comparables to K991225.
TERUMO U-100 INSULIN SYRING
K001474 · Terumo Medical Corp. · Jun 2000
VACLOK SYRINGE
K994253 · Merit Medical Systems, Inc. · Jan 2000
TERUMO U-100 INSULIN SYRINGE
K992802 · Terumo Medical Corp. · Sep 1999
MONOJECT INSULIN SYRINGE
K991758 · The Kendal Co. · Jun 1999
STERILE WATER FOR INJECTION PREFILLED SYRING (SWFIPS)
K972728 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Jul 1998
BECTON DICKINSON SYRINGES
K980580 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Jun 1998